Cargando…
Neutrophil elastase and its therapeutic effect on leukemia cells
Neutrophil elastase (NE) is an early myeloid-specific serine protease, which is predominantly produced by promyelocytes. A previous study demonstrated that NE has an important role in the development of acute promyelocytic leukemia (APL). The process of APL was shown to be accelerated in animals tha...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526057/ https://www.ncbi.nlm.nih.gov/pubmed/26081156 http://dx.doi.org/10.3892/mmr.2015.3946 |
_version_ | 1782384374971367424 |
---|---|
author | JIANG, KAI-LING MA, PENG-PENG YANG, XIAO-QUN ZHONG, LIANG WANG, HUI ZHU, XIN-YU LIU, BEI-ZHONG |
author_facet | JIANG, KAI-LING MA, PENG-PENG YANG, XIAO-QUN ZHONG, LIANG WANG, HUI ZHU, XIN-YU LIU, BEI-ZHONG |
author_sort | JIANG, KAI-LING |
collection | PubMed |
description | Neutrophil elastase (NE) is an early myeloid-specific serine protease, which is predominantly produced by promyelocytes. A previous study demonstrated that NE has an important role in the development of acute promyelocytic leukemia (APL). The process of APL was shown to be accelerated in animals that expressed abundant NE, whereas NE-deficient mice were protected from APL development; thus suggesting an important role for NE in the development of APL. The present study aimed to investigate the effects and possible mechanisms of NE. Up- and downregulation of NE in various leukemia cell lines was conducted in order to explore its significance in the occurrence and procession of leukemia, with the aim of identifying novel targeted therapeutic drugs for the treatment of leukemia. NE was overexpressed in cells following infection with an adenovirus, and Cell Counting kit-8 and flow cytometry results demonstrated that cell proliferation was promoted, and cell apoptosis was inhibited, as compared with the untreated cells. NE was downregulated in the cells by both RNA interference and treatment with GW311616A, a specific inhibitor of NE, following which cell growth was shown to be inhibited and apoptosis was induced. These results suggested that NE may promote the development of APL, therefore, NE may be a therapeutic target and its inhibitor GW311616A may be a potential therapeutic drug for leukemia. Furthermore, the apoptosis-associated protein B-cell lymphoma 2 (Bcl-2)-associated X protein was significantly increased, whereas Bcl-2 was markedly decreased in the cells with downregulated NE. Further experiments revealed that the probable apoptosis-associated signaling pathway was the phosphoinositide 3-kinase/AKT pathway. The present study is the first, to the best of our knowledge, to demonstrate that GW311616A, a specific NE inhibitor, may act as a potential targeted drug for leukemia, which may have a profound impact on the future of leukemia-targeted therapy. |
format | Online Article Text |
id | pubmed-4526057 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | D.A. Spandidos |
record_format | MEDLINE/PubMed |
spelling | pubmed-45260572015-11-30 Neutrophil elastase and its therapeutic effect on leukemia cells JIANG, KAI-LING MA, PENG-PENG YANG, XIAO-QUN ZHONG, LIANG WANG, HUI ZHU, XIN-YU LIU, BEI-ZHONG Mol Med Rep Articles Neutrophil elastase (NE) is an early myeloid-specific serine protease, which is predominantly produced by promyelocytes. A previous study demonstrated that NE has an important role in the development of acute promyelocytic leukemia (APL). The process of APL was shown to be accelerated in animals that expressed abundant NE, whereas NE-deficient mice were protected from APL development; thus suggesting an important role for NE in the development of APL. The present study aimed to investigate the effects and possible mechanisms of NE. Up- and downregulation of NE in various leukemia cell lines was conducted in order to explore its significance in the occurrence and procession of leukemia, with the aim of identifying novel targeted therapeutic drugs for the treatment of leukemia. NE was overexpressed in cells following infection with an adenovirus, and Cell Counting kit-8 and flow cytometry results demonstrated that cell proliferation was promoted, and cell apoptosis was inhibited, as compared with the untreated cells. NE was downregulated in the cells by both RNA interference and treatment with GW311616A, a specific inhibitor of NE, following which cell growth was shown to be inhibited and apoptosis was induced. These results suggested that NE may promote the development of APL, therefore, NE may be a therapeutic target and its inhibitor GW311616A may be a potential therapeutic drug for leukemia. Furthermore, the apoptosis-associated protein B-cell lymphoma 2 (Bcl-2)-associated X protein was significantly increased, whereas Bcl-2 was markedly decreased in the cells with downregulated NE. Further experiments revealed that the probable apoptosis-associated signaling pathway was the phosphoinositide 3-kinase/AKT pathway. The present study is the first, to the best of our knowledge, to demonstrate that GW311616A, a specific NE inhibitor, may act as a potential targeted drug for leukemia, which may have a profound impact on the future of leukemia-targeted therapy. D.A. Spandidos 2015-09 2015-06-17 /pmc/articles/PMC4526057/ /pubmed/26081156 http://dx.doi.org/10.3892/mmr.2015.3946 Text en Copyright © 2015, Spandidos Publications http://creativecommons.org/licenses/by/3.0 This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited. |
spellingShingle | Articles JIANG, KAI-LING MA, PENG-PENG YANG, XIAO-QUN ZHONG, LIANG WANG, HUI ZHU, XIN-YU LIU, BEI-ZHONG Neutrophil elastase and its therapeutic effect on leukemia cells |
title | Neutrophil elastase and its therapeutic effect on leukemia cells |
title_full | Neutrophil elastase and its therapeutic effect on leukemia cells |
title_fullStr | Neutrophil elastase and its therapeutic effect on leukemia cells |
title_full_unstemmed | Neutrophil elastase and its therapeutic effect on leukemia cells |
title_short | Neutrophil elastase and its therapeutic effect on leukemia cells |
title_sort | neutrophil elastase and its therapeutic effect on leukemia cells |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526057/ https://www.ncbi.nlm.nih.gov/pubmed/26081156 http://dx.doi.org/10.3892/mmr.2015.3946 |
work_keys_str_mv | AT jiangkailing neutrophilelastaseanditstherapeuticeffectonleukemiacells AT mapengpeng neutrophilelastaseanditstherapeuticeffectonleukemiacells AT yangxiaoqun neutrophilelastaseanditstherapeuticeffectonleukemiacells AT zhongliang neutrophilelastaseanditstherapeuticeffectonleukemiacells AT wanghui neutrophilelastaseanditstherapeuticeffectonleukemiacells AT zhuxinyu neutrophilelastaseanditstherapeuticeffectonleukemiacells AT liubeizhong neutrophilelastaseanditstherapeuticeffectonleukemiacells |